• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron.接种疫苗后的德尔塔变异株感染可引发针对严重急性呼吸综合征冠状病毒 2 型奥密克戎的强烈中和免疫。
J Infect Dis. 2022 Nov 1;226(9):1551-1555. doi: 10.1093/infdis/jiac149.
2
Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.奥密克戎变异株疫苗突破性感染诱导针对 SARS-CoV-2 奥密克戎 BA.1 的交叉中和反应优于单独感染。
Int J Mol Sci. 2022 Jul 12;23(14):7675. doi: 10.3390/ijms23147675.
3
Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing.野生型 SARS-CoV-2 中和抗体的免疫活性会随着时间推移和变异株的不同而降低,但与诊断检测有很好的相关性。
Front Immunol. 2023 Feb 8;14:1055429. doi: 10.3389/fimmu.2023.1055429. eCollection 2023.
4
Omicron infection increases IgG binding to spike protein of predecessor variants.奥密克戎感染增加了 IgG 对前变体刺突蛋白的结合。
J Med Virol. 2023 Feb;95(2):e28419. doi: 10.1002/jmv.28419.
5
Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection.序列很重要:感染后进行初级 COVID-19 疫苗接种会引起相似的刺突抗体水平,但比突破性感染产生更强的抗体依赖的细胞介导的细胞毒性。
J Immunol. 2024 Oct 15;213(8):1105-1114. doi: 10.4049/jimmunol.2400250.
6
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.初次感染 SARS-CoV-2 奥密克戎 BA.1 和 BA.2 株后中和抗体的不同反应特征
Front Immunol. 2022 Jul 19;13:946318. doi: 10.3389/fimmu.2022.946318. eCollection 2022.
7
Sequentially immune-induced antibodies could cross-neutralize SARS-CoV-2 variants.连续诱导的抗体可中和 SARS-CoV-2 变体。
Animal Model Exp Med. 2022 Feb;5(1):89-93. doi: 10.1002/ame2.12216.
8
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.由 BNT162b2 mRNA 疫苗诱导的人血清对 SARS-CoV-2 奥密克戎的中和作用。
Science. 2022 Feb 11;375(6581):678-680. doi: 10.1126/science.abn7591. Epub 2022 Jan 18.
9
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.恢复期和疫苗血清对 SARS-CoV-2 奥密克戎变体的活性。
Nature. 2022 Feb;602(7898):682-688. doi: 10.1038/s41586-022-04399-5. Epub 2021 Dec 31.
10
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.接种第三剂 BNT162b2 加强针后针对 SARS-CoV-2 德尔塔和奥密克戎变异株的中和活性 根据三种同源或异源 COVID-19 接种方案。
Front Cell Infect Microbiol. 2022 Jul 11;12:948014. doi: 10.3389/fcimb.2022.948014. eCollection 2022.

引用本文的文献

1
Long-term immunogenicity in previously vaccinated healthcare workers with inactivated virus vaccine after SARS-CoV-2 infection or booster vaccination.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染或加强疫苗接种后,既往接种过灭活病毒疫苗的医护人员的长期免疫原性。
Vaccine X. 2023 Aug;14:100334. doi: 10.1016/j.jvacx.2023.100334. Epub 2023 Jun 20.
2
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study.在以色列家庭中暴露于 SARS-CoV-2 的接种个体中 COVID-19 感染和症状性疾病严重程度的保护相关性(ICoFS):一项前瞻性队列研究。
Lancet Microbe. 2023 May;4(5):e309-e318. doi: 10.1016/S2666-5247(23)00012-5. Epub 2023 Mar 21.
3
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update.用于COVID-19治疗的康复期血浆(高免疫球蛋白):最新情况
Process Biochem. 2023 Apr;127:66-81. doi: 10.1016/j.procbio.2023.01.018. Epub 2023 Jan 31.

接种疫苗后的德尔塔变异株感染可引发针对严重急性呼吸综合征冠状病毒 2 型奥密克戎的强烈中和免疫。

Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron.

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.

出版信息

J Infect Dis. 2022 Nov 1;226(9):1551-1555. doi: 10.1093/infdis/jiac149.

DOI:10.1093/infdis/jiac149
PMID:35429398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9047231/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant extensively escape neutralizing antibodies by vaccines or infection. We assessed serum neutralizing activity in sera from Delta infection after vaccination and Delta infection only against SARS-CoV-2 Wuhan-Hu-1 (WA1), Beta, Delta, and Omicron. Sera from Delta infection only could neutralize WA1 and Delta but almost completely lost capacity to neutralize Beta and Omicron. However, Delta infection after vaccination resulted in a significant increase of serum neutralizing activity against WA1, Beta, and Omicron. This study demonstrates that breakthrough infection of Delta substantially induced high potency humoral immune response against the Omicron variant and other emerged variants.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)奥密克戎(B.1.1.529)变体通过疫苗或感染广泛逃避中和抗体。我们评估了血清中和活性,血清来自 Delta 感染后的疫苗接种和 Delta 感染仅针对 SARS-CoV-2 武汉-Hu-1(WA1)、贝塔、德尔塔和奥密克戎。仅 Delta 感染的血清可中和 WA1 和德尔塔,但几乎完全丧失中和贝塔和奥密克戎的能力。然而,Delta 感染后的疫苗接种导致针对 WA1、贝塔和奥密克戎的血清中和活性显著增加。这项研究表明,Delta 的突破性感染大大诱导了针对奥密克戎变体和其他出现变体的高效力体液免疫反应。